Added Pharma presents practical solutions for the safe filling and labelling of large quantities of syringes in the hospital pharmacy with the help of its syringe filling machine and its large volume (1000ml to 5000ml) sterile IV-drug solution bag. You are more than welcome for a demonstration in our stand. You can also contact us via email (info[at]addedpharma[dot]com) or telephone (+31-412-627700)

The continuous drive for improvements based on the daily routine of the healthcare professional makes Alphatron Medical Innovations stand out. Therefore, solutions are more about personal effectiveness than just the combination of hard and software.

This results in the solutions for mobile and efficient workflows at the patient's bedside. AMiS is specially designed to create a modular and mobile carestation that gives the caregiver access to the EPR, Medication and Vital signs.

Alphatron Medical Innovations; Creating flow in healthcare

www.alphatroninnovations.com

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Amgen was one of the first companies to recognize the potential of modern biotechnology in developing valuable medicines for patients – and to assemble the diverse set of skills necessary to advance from textbook to applied science. Today, we are applying our deep scientific capabilities from more than three decades of experience to the development of biosimilars and continuing our legacy of providing patients with vital medicines. We currently have a robust pipeline with several biosimilar molecules in development which target some of the most complex and important oncology and inflammation antibody biologics.

We provide scalable, comprehensive pharmacy solutions – from drug order to delivery, prescription to patient – for every segment of the pharmacy market including but not limited to health systems, long-term care, retail and central processing.

Recognized for quality and integrity, our offerings are also supported by unmatched industry knowledge. Our solutions include automated IV compounding, compliance packaging management, inventory control and storage, workflow and scheduling software, vial-filling automation, expert consultation, product / workflow design and much more.

Contact us today to learn how ARxIUM can advance your clinical, operational and financial performance.

Every service provided by B. Braun incorporates its entire expertise and the company's deep understanding of users' needs.

In developing its products, product systems and services, B. Braun acts like a sparring partner. A companion who promotes developments through constructive dialog and the motivation to improve things. With its constantly growing portfolio of effective medical care solutions, B. Braun makes a substantial contribution towards protecting and improving people's health.

At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

Our latest release was MAPP®, an Android based Mobile Application Platform that combines all nursing activities into a single handheld device, not only providing increased mobility and productivity but reassuring Patient Safety through Barcode Scanning. Actions performed on MAPP® are automatically integrated with HIS and patient EMR. Apps such as validation of medication administration, safe blood transfusion, ward stock manage or record nursing procedures are accessible in MAPP®.

Our solutions are present worldwide and marketed through our distributor/partner network that we wish to broaden in EAHP. 

BTC Medical Europe works side by side with pharmacists, laboratory technicians and nurses to identify needs and providing the best solutions to them. The product offering is constantly expanding with a great focus on safety and protection, both for patients and for hospital operators.

BTC Medical Europe is also able to develop customized, OEM solutions for pharmaceutical and biomedical companies, thanks to the ability to cover all development phases, from design to certification, from manufacturing to marketing.

The team of skilled quality, design and production experts offers its competence in material selection, manufacture design, product/process design and validations in order to ensure our costumers' products being released to the market with very high standards and in a timely manner.

In December 2016, BTC Medical Europe's has been acquired by Sidam Srl. BTC thus entered the Synopo Group, strengthening its presence in the market, thanks to the synergies with the other companies part of the group.

We strive to contribute to progress through the development of innovative technologies and sustainable solutions, according to the latest GMP (Good Manufacturing Practice) regulations. We continue to implement large investments in Research & Development in order to be at the forefront and maintain a technological advantage in the sector. In the field of Pharma for aseptic processing of pharmaceutical products Comecer develops standard and tailored solutions for the production of isolators for the treatment of toxic and non-toxic substances to be used in pharmaceutical production companies, in university research centres, in hospitals, and in small as well as in large industrial groups worldwide. We gained experience in manual and semi-automatic sterile processing of cytotoxic antiblastic drugs in hospital pharmacies. All systems are tested and undergo a comprehensive series of validation checks according to the applicable standards and norms. The "Safety First" Code of Ethics applies inside Comecer, which translates into quality of materials and processes and allows Comecer to qualify its products in accordance with the highest standards in the sector.

Today, Deenova, together with its French subsidiary ECO-DEX, is the leading European Group in robotic solutions for the unit dose medicines management.

Deenova introduced a new business model; operates as a service provider and offers hospitals and nursing homes flexible and made-to-measure solutions.
For more information, please visit www.deenova.com

.

With more than 20 years in technology of containment, our team provides you customized solution on a very safe way. Based in Paris, EuroBioConcept is to be found all over the world, with distributors and partner companies in sales and service.
EuroBioConcept protects both products and operators. www.eurobioconcept.fr

With the internet based AKDA drug information Tool (developped by the Drug Information Working Group of the German Association of Hospital Pharmacists) an efficient organization and documentation of this service is possible, guaranteed by more than 10 years of experience. Already 230 hospital pharmacies in Germany and other European countries use this tool, which is available in English, Spanish and German. The database is regularly adapted to the needs of the users. Since launch in 2003, over 60,000 complex enquiries and thoroughly researched answers were documented, either at the password-protected individual level of each pharmacy departement or at the European sharing level.

The AKDA drug information Tool ensures a high standard of quality in accordance with DIN 15224 "QM in health care", which requires an evidence-based and scientific substantiation of physicians´ and pharmacists´ actions. Since 2015 the database is part of the "European Union for Patient Safety and Quality of Care (www.pasq.eu)", containing national patient safety projects.

We produce essential plasma medicines for patients to treat rare, chronic and, at times, life-threatening conditions. The company provides a comprehensive portfolio of solutions in transfusion medicine and also offers hospitals, pharmacies and healthcare professionals information and services that deliver efficient, expert medical care.

Grifols, with more than 21,000 employees in 30 countries, is committed to a sustainable business model that shapes the future of healthcare and sets the standard for innovation, quality, safety and ethical leadership in the industry.

For more information, please visit grifols.com.

Everything we do is driven by the understanding we are all patients, so our team of dedicated employees is committed to delivering quality, consistency and reliability throughout everything we do.

Pharmacists and other healthcare professionals rely on our expertise and experience in the area of parenteral formulations. Our labelling is constantly evolving using intelligent packaging design to help reduce the risk of medication errors. We have also developed standardised drug infusion concentrations for use (Ready-to-Use solutions) in intensive care units. We listen, we learn and we turn ideas into solutions.

Today, our products are available in more than 40 countries throughout the world.

For more information, please visit us in the exhibition hall.

www.hameln.co.uk
www.hameln-plus.com

We combine data-driven analytics and advisory services with advanced technologies such as AI to give you evidence-based clinical decision support. And with our experience across oncology, genomics, clinical trials, radiology and medication management, we aim to help you deliver high-quality healthcare well into the future.

Our technology is supported by a team of experienced health and care professionals who understand the healthcare challenges you face, and have the experience and insight to support clinical and operational excellence.

For 50 years, IMI has worked closely with pharmacists and compounding professionals to create innovative devices that meet very specialized needs. Throughout this time, IMI has established long-standing partnerships with some of the biggest names in healthcare. Through these partnerships and directly, IMI is delivering the high-quality and high-value products that pharmacy operations demand. All IMI products are manufactured in the USA under the strictest quality standards at their FDA licensed, ISO 13485 certified facility.

At the core of IMI's product line, you will find our unique tamper-evident technologies. These products offer an active deterrent to potential drug diversion and misuse. Our tamper-evident products are an essential component of a health system's total drug security program.

We believe that our customers and the patients they serve deserve only the highest level of quality and security. We are committed to our customer's satisfaction. When you partner with us, you not only receive high-quality devices from the industry leader in Tamper Evident Cap Technology, you also receive a dedicated team of support professionals available to you when you need them. Our mission is to build long-lasting relationships with pharmaceutical and compounding professionals to continuously advance our devices to serve the healthcare industry.

Throughout its over 100 year history, FIP's priorities have expanded both literally and figuratively to meet the needs and expectations of the profession in expanding healthcare services and integrating emerging scientific developments. Changes in pharmacy and the emergence of Pharmacy Practice as a cornerstone of the profession have lead FIP to become globally visible for its advocacy on behalf of the role of the pharmacist in the provision of healthcare, while still maintaining its grounding in the pharmaceutical sciences. 

In parallel, the membership of FIP has evolved to become the most extensive global pharmacy and pharmaceutical sciences network. This network is continuing to expand its presence and influence through partnerships with some of the world’s leading healthcare, educational and scientific institutions.

This year FIP's annual World congress of pharmacy and pharmaceutical sciences will take place in Glasgow, UK, 2-6 September 2018 under the theme of: "Pharmacy: Transforming Outcomes! New ways for pharmacy to provide better patient care." The congress is accredited (ACPE and others). It's preceded by: Immunization training, Pharmacy Technicians symposium, Biosimilar workshop, the AIM Global Deans Forum and the Young Pharmacists Group Leadership Training. The FIP congress welcomes 4000 pharmacists from over 100 countries representing all fields of pharmacy. It's the global platform for networking and cross-fertilization.

LEVENTON has become a worldwide market leader in development, manufacturing and distribution of infusion medical devices, offering solutions and benefits very appreciated for patients and professionals for all infusion therapies. 

Medi-Dose provides tamper-evidence, ultraviolet inhibitance and moisture protection. No glass, metal, large capital expense or formal training is required. For more information, visit www.medidose.com.

We are committed to improving patient outcomes through product designs that meet safety, clinical, and regulatory guidelines while supporting cost containment objectives.

At Omnicell, we’re inspired to create safer and more efficient ways to manage medications and supplies across all care settings. By automating what are often disconnected, manual, and at times dangerous processes, we’re helping to improve clinical and financial outcomes, allowing caregivers to focus on what’s most important—the patient.

We work with healthcare providers to drive operational efficiency by removing tedious tasks and waste.
Regardless of distribution model, our solutions automate manual processes—including ordering, receiving, stocking, and picking medications. 

Leveraging a unified platform, our inventory management solutions and services give visibility to opportunities to optimize workflows, monitor inventory, and reduce costs.

Our business concept is to manufacture the unique endless bag system Longopac that, thanks to innovative, smarter waste management and packaging solutions, creates a better working environment for different segments. Our successes are possible because our products offer rational handling, a better working environment and low environmental impact. Our bag system is based on a strong, 3-layer polyethylene bag material which is folded into compact cassettes that today is sold in more than 40 countries. Our main product for hazardous waste handling is Pactosafe. It is a waste sealing unit for safe airtight sealing of cytotoxic waste, smelly waste and toxic laboratory waste.

Stockley's Interactions Checker and Martindale's Adverse Reactions Checker from the Royal Pharmaceutical Society, and the reference resources Stockley's Drug Interactions and Martindale: The Complete Drug Reference provide healthcare professionals like you with essential information to enable quick decisions at the point of care, communicate confidently and free up time to focus on patient wellbeing. Find out more at https://about.medicinescomplete.com 

Providing flexible software and hardware solutions tailored to your business needs, we can have your Hospital fully FMD compliant quickly and easily.

Our continuous software development road map allows us to offer our customers 'Best In Class' solutions both now and into the future.

Feel free to contact our dedicated FMD Customer Support Team who look forward to making your journey to FMD compliance Easy.

www.quickpharmsolutions.com

The TOXI-GUARD® patent system, located in the vial adaptor, allows pressure equalization during use, prevents the escape of hazardous drug vapors into the environment during drug reconstitution and administration and prevents airborne contaminants and particles from entering the drug vial.

STOCKART modules enable real-time monitoring of meds and supplies from hospital warehouses to pharmacies, wards and patients. By optimizing the clinical care and supply chain processes the modules improve patient safety and reduce hospital costs. All medical supplies and meds including IV liquids, narcotics and cold chain meds can be monitored within a hi-security environment. STOCKART modules have been designed to meet all needs of hospitals and can be customized according to any institution's needs. For more information please visit our website www.stockart.com.tr/en

Our extensive R&D commitment to finding new materials and processes ensure new and novel solutions for our clients' bag needs. Empty bags for Chemotherapy, Parenteral nutrition, drug reconstitution, etc. 

Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2014 sales of $1.42 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.